| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet |  | | 2020 | 789 | 14 |
|
| High-quality health systems: time for a revolution in research and research funding | The Lancet Global Health |  | | 2019 | 400 | 199 |
|
| Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review | BMC Public Health | | | 2019 | 432 | 693 |
|
| Maladies parasitaires émergentes | Revue médicale suisse | | | 2014 | 640 | 2 |
|
| Strongyloïdiase: corticothérapie et dermite linéaire prurigineuse | Dermatologica Helvetica | | | 2014 | 272 | 116 |
|
| Pediatric Chagas disease in Europe: 45 cases from Spain and Switzerland | The Pediatric infectious disease journal | | | 2014 | 639 | 1 |
|
| Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Medecins Sans Frontieres Experience in the Democratic Republic of the Congo | Clinical infectious diseases | | | 2013 | 708 | 532 |
|
| Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non-endemic country | TM & IH. Tropical medicine and international health | | | 2012 | 725 | 0 |
|
| Visceral leishmaniasis in a kidney transplant recipient: parasitic interstitial nephritis, a cause of renal dysfunction | American journal of transplantation | | | 2010 | 711 | 0 |
|
| Congenital transmission of Chagas disease in Latin American immigrants in Switzerland | Emerging infectious diseases | | | 2009 | 637 | 0 |
|
| Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda | TM & IH. Tropical medicine and international health | | | 2009 | 608 | 0 |
|
